Paul Lin

8PUBLICATIONS

89CO-AUTHORS

Transplantation immunologyPredictive and prognostic markersRegenerative medicine (incl. stem cells)Gene and molecular therapyReaction engineering (excl. nuclear reactions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 05, 2026

D-VRD induction and autologous transplant in patients ≥70 years.

|Oct 27, 2025

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Nov 01, 2024

Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.

Oren Pasvolsky, Curtis Marcoux, Denái R Milton

|Sep 11, 2024

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|Jun 20, 2024

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Sunil Acharya, Rafet Basar, May Daher

|May 17, 2024

Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.

Oren Pasvolsky, Zhongya Wang, Denái R Milton

Pageof 2

Frequent Collaborators

Katayoun Rezvani

May Daher

Hind Rafei

Vakul Mohanty

Ken Chen

Elizabeth J Shpall

Sunil Acharya

Rafet Basar

Mecit Kaplan

Ye Li

Frequent Collaborators

Katayoun Rezvani

May Daher

Hind Rafei

Vakul Mohanty